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Abstract
Recent genome-wide association scans (GWAS) and meta-analysis studies on European populations have identified many
genes previously implicated in lipid regulation. Validation of these loci on different global populations is important in
determining their clinical relevance, particularly for development of novel drug targets for treating and preventing diabetic
dyslipidemia and coronary artery disease (CAD). In an attempt to replicate GWAS findings on a non-European sample, we
examined the role of six of these loci (CELSR2-PSRC1-SORT1 rs599839; CDKN2A-2B rs1333049; BUD13-ZNF259 rs964184;
ZNF259 rs12286037; CETP rs3764261; APOE-C1-C4-C2 rs4420638) in our Asian Indian cohort from the Sikh Diabetes Study
(SDS) comprising 3,781 individuals (2,902 from Punjab and 879 from the US). Two of the six SNPs examined showed
convincing replication in these populations of Asian Indian origin. Our study confirmed a strong association of CETP
rs3764261 with high-density lipoprotein cholesterol (HDL-C) (p=2.03610
226). Our results also showed significant
associations of two GWAS SNPs (rs964184 and rs12286037) from BUD13-ZNF259 near the APOA5-A4-C3-A1 genes with
triglyceride (TG) levels in this Asian Indian cohort (rs964184: p=1.74610
217; rs12286037: p=1.58610
22). We further
explored 45 SNPs in a ,195 kb region within the chromosomal region 11q23.3 (encompassing the BUD13-ZNF259, APOA5-
A4-C3-A1, and SIK3 genes) in 8,530 Asian Indians from the London Life Sciences Population (LOLIPOP) (UK) and SDS cohorts.
Five more SNPs revealed significant associations with TG in both cohorts individually as well as in a joint meta-analysis.
However, the strongest signal for TG remained with BUD13-ZNF259 (rs964184: p=1.06610
239). Future targeted deep
sequencing and functional studies should enhance our understanding of the clinical relevance of these genes in
dyslipidemia and hypertriglyceridemia (HTG) and, consequently, diabetes and CAD.
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Introduction
Dyslipidemia, with low levels of high-density lipoprotein
cholesterol (HDL-C) and high levels of low-density lipoprotein
cholesterol (LDL-C) and triglycerides (TG), is a well established
risk factor for coronary artery disease (CAD) and a significant
cause of mortality in individuals with type 2 diabetes (T2D) [1].
The risk of developing CAD is 2–3 times higher in diabetic
males and 4–5 times higher in diabetic females compared to
male and female non-diabetics [2]. There is considerable ethnic
difference in the prevalence and progression of T2D and CAD;
the incidences of these diseases are about 3–5 times higher in
Asian Indians compared to Euro-Caucasians [3]. Lipid levels are
widely measured in clinical practice and are used as therapeutic
targets for prevention and treatment of CAD especially in
patients with diabetes [4]. Recent genome-wide association scans
(GWAS) and meta-analysis studies in European populations have
identified common variants in many genes, including previously
known loci that are potentially involved in lipid regulation [5–8].
High heritability (40% to 60%) of lipid traits and strong
association signals among common variants in these genes
involved in lipid metabolism provide a strong rationale to search
for causal variants that may uncover novel pathways crucial for
lipid regulation and eventually lead to treatment or prevention of
CAD [9,10]. Replication of GWAS signals in different ethnic
groups is important as the frequency of the susceptible alleles at
these loci may vary significantly between world populations [11].
Also, these studies can help identify population-specific environ-
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with specific demographic and cultural histories [11]. In
particular, replication of GWAS loci associations will have more
relevance in population groups with high disease burdens such as
Asian Indians [12].
A few studies have reported associations of these novel loci with
lipid traits in Asian Indian immigrants living in the UK [6,13,14].
The present investigation was carried out to examine the role of six
of the most strongly associated and extensively replicated GWAS
loci (CELSR2-PSRC1-SORT1 rs599839; CDKN2A-2B rs1333049;
BUD13-ZNF259 rs964184; ZNF259 rs12286037; CETP
rs3764261; APOE-C1-C4-C2 rs4420638) (summarized in Table 1)
in our Asian Indian cohort from the Sikh Diabetes Study (SDS)
[15]. By further expanding our search around a ,195 kb region
within the chromosomal region 11q23.3 surrounding BUD13-
ZNF259, APOA5-A4-C3-A1, and SIK3 gene clusters in 8,530 Asian
Indian individuals, we not only confirmed the strongest signal
associating rs964184 (from the inter-genic region of BUD13-
ZNF259) with TG, but also discovered strong association in several
other SNPs in this region using single-SNP association and
haplotype analysis.
Results
Table 2 summarizes and compares the general characteristics of
the Punjabi and US cohorts used in this investigation. The US
cohort was younger and had an earlier onset of T2D (42.4618.9
years) compared to the Punjabi cohort (47.6611.1 years).
Diabetics in the Punjabi cohort had poorer glycemic control
showing significantly higher fasting blood glucose (FBG ) levels by
,28 mg/dL (p=0.002), and had a significantly higher waist to hip
ratio (WHR) (by 5 percentage points) (p=0.001), compared to the
US cohort. As expected, T2D cases had significantly higher fasting
TG (p,0.0001) and significantly lower HDL-C (p,0.0001)
compared to normoglycemic (NG) controls. No SNP genotype
deviated significantly from Hardy-Weinberg expectations (HWE)
in the NG controls. Of these SNPs, no variant revealed any
significant evidence of association with T2D or CAD in this
population after adjusting for age, gender, and body mass index
(BMI) (data not shown).
Association of CETP Variant with HDL and Triglyceride
Levels
We investigated the association of all six variants with
quantitative traits associated with obesity, blood glucose and
serum lipids in NG and T2D individuals from both the Punjabi
and US cohorts. None of the investigated SNPs showed any
significant association with obesity (BMI, WHR), or glucose traits
(FBG, 2 h glucose, fasting insulin, insulin resistance [HOMA-IR]
and b-cell function [HOMA-B]) (data not shown). Multiple linear
regression analysis revealed a strongly significant association of the
‘A’ allele of rs3764261 (CETP) with HDL-C in the NG (b=0.09,
p=1.14610
26), T2D (b=0.07, p=0.014) and combined
(NG+T2D) (b=0.09, p=1.21610
24) groups in the Punjabi
cohort was observed. Similar strong association of this SNP with
HDL-C was seen in the NG (b=0.11, p=0.006) and NG+T2D
(b=0.10, p=1.72610
29) groups from the US cohort (Tables 3, 4).
Further meta-analysis using the Punjabi and US cohorts revealed
a strong association of this variant with HDL-C in both fixed-effect
(b=0.14, p=2.03610
226) and random-effect (b=0.15,
p=4.84610
24) models. Interestingly, the same ‘A’ allele carriers
of CETP also showed a significant decrease in TG (b=20.12,
p=1.02610
24) in the T2D Punjabi cohort (Table 3).
Association of BUD13-ZNF259 Variants with Triglyceride
Levels
A strong and consistent association of an inter-genic variant
near BUD13-ZNF259 (rs964184) with TG in both the Punjabi and
US cohorts in all additive, dominant, and recessive genetic models,
even after controlling for covariates of age, gender, BMI and
disease status, where necessary. As shown in Table 3 and 4, TG
levels were consistently raised among minor ‘G’ risk allele carriers
in the NG group in Punjabi (b=0.10, p=0.001) and US (b=0.12,
p=0.005) cohorts, the T2D group in the Punjabi (b=0.16,
Table 1. Details of the investigated loci.
Gene SNP Chr. Position Trait Allele
Ref.
Freq.
SDS
Freq. p-value Effect
Population/
Study References
CELSR2-PSRC1-SORT1 rs599839 Chr 1:109623689 LDL A/G* 0.21 0.26 1.7610
215 20.1 Caucasian Sandhu et al, 2008, Lancet
LDL A/G 0.77 6.1610
233 5.5 FUSION Willer et al, 2008, Nat Genet
LDL A/G 0.08 3.1610
211 24.7 Japanese Nakayama et al, 2009, J Med Genet
CDKN2A-2B rs1333049 Chr 9:22115503 CAD C/G 0.47 0.50 1.2610
213 0.4 WTCCC Burton et al, 2007, Nature
MI C/G 0.50 0.02 0.1 Hispanics Qi et al, 2011, Circulation
BUD13-ZNF259 rs964184 Chr 11:116648917 TG C/G 0.14 0.20 4610
262 0.3 FHS Kathiresan et al, 2008, Nat Genet
TG C/G 0.13 7610
2240 16.9 Caucasian Teslovich et al, 2010, Nature
TG C/G 0.14 5.4610
224 – Caucasian Johansen et al, 2010, Nat Genet
HDL C/G 0.14 1610
212 20.2 FHS Kathiresan et al, 2008, Nat Genet
ZNF259 rs12286037 Chr 11:116157417 TG C/T 0.94 0.96 1.0610
226 25.8 FUSION Willer et al, 2008, Nat Genet
CETP rs3764261 Chr 16:55550825 HDL C/A 0.69 0.64 2.3610
257 3.5 FUSION Willer et al, 2008, Nat Genet
HDL C/A 0.32 7610
2380 3.4 Caucasian Teslovich et al, 2010, Nature
APOE-C1-C4-C2 rs4420638 Chr 19:50114786 LDL G/A 0.82 0.89 3.0610
243 6.6 FUSION Willer et al, 2008, Nat Genet
LDL G/A 0.16 4610
227 0.3 FHS Kathiresan et al, 2008, Nat Genet
LDL G/A 0.17 9610
2147 7.1 Caucasian Teslovich et al, 2010, Nature
*fonts in bold indicate risk allele.
doi:10.1371/journal.pone.0037056.t001
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27), and in the NG+T2D groups in the Punjabi
(b=0.15, p=5.94610
210) and US (b=0.19, p=1.12610
25)
cohorts. Moreover, the effect sizes indicated by regression
coefficients (b) were consistently higher in T2D cases compared
to NG controls (e.g. for rs964184, b=0.16; p=9.63610
27 in T2D
cases vs. b=0.10, p=0.001 in NG controls). A similar significant
increase in VLDL-C was seen among the NG and T2D groups
from the Punjabi and US cohorts (data not shown). The
association of this variant with TG also was statistically significant
in meta-analysis for both the fixed-effect (b=0.16, 1.74610
217)
and random-effect (b=0.16, 1.74610
217) models (Table 5). The
other intronic variant (rs12286037) in ZNF259 was also strongly
associated with TG in the Punkabi T2D group (b=0.09,
p=0.004) and the NG+T2D groups (b=0.07, p=0.003;
0.14 p=0.002) in both the Punjabi and US cohorts, as well as
in meta-analysis (b=0.09, p=1.58610
22) using either fixed- or
random-effect models. This variant also revealed a strong
association with total cholesterol in US cohort both in the NG
(b=0.11, p=0.009) and NG+T2D (b=0.18, p=3.58610
25)
groups (Table 4).
Additional Variants Associated with Serum Lipids
Among other variants, an association for CELSR2-PSRC1-
SORT1 (rs599839) showed a marginally significant decrease in
Table 2. Clinical characteristics of study subjects (Mean 6 SD).
Punjabi Cohort
n=2,902 p value
Y
US Cohort
n=879 p value
Y
Combined Cohorts
n=3,781 p value
Y
Age (yrs.) 53.8613.0 48.0613.5 52.5613.3
% Males 55.8 51.7 54.9
Age at Diagnosis (yrs.) 47.6611.1 42.4618.9 47.4611.6
Duration of Diabetes (yrs.) 7.766.8 6.867.2 7.666.8
BMI (kg/m
2) 26.565.0 26.864.3 25.367.3
Waist (cm) 93.1612.1 92.5613.4 92.9612.4
WHR 0.9560.07 0.90611.0* 0.9460.10
Blood Pressure (mm/Hg)
Systolic 137.6623.6 129.6620.9 135.7623.2
Diastolic 81.8612.8 81.3611.2 81.7612.5
FBG (mg/dL)
Non-Diabetic 95.3612.1 ,0.0001 95.7610.1 ,0.0001 95.4611.5 ,0.0001
Diabetic 179.9673.7 152.4646.6** 177.2672.0
2 h glucose (mg/dL)
Non-Diabetic 105.2619.2 ,0.0001 109.3617.1 ,0.0001 107.0618.4 ,0.0001
Diabetic 190.1673.1 239.6674.6
¥ 201.0676.2
Cholesterol (mg/dL)
Non-Diabetic 171.2654.2 0.283 188.8645.0 0.001 177.6652.1 0.047
Diabetic 173.6648.4 174.7645.9 173.7648.1
Triglyceride (mg/dL)
Non-Di1abetic 147.8671.8 0.001 121.8671.1 ,0.0001 137.0673.2 ,0.0001
Diabetic 159.3684.1 167.5694.8 160.2685.3
HDL Cholesterol (mg/dL)
Non-Diabetic 38.1615.4 0.001 42.2614.2 0.001 39.5615.2 ,0.0001
Diabetic 36.1612.8 37.8616.4 36.3613.1
LDL Cholesterol (mg/dL)
Non-Diabetic1 100.9637.2 0.522 122.8634.8 0.003 108.1638.2 ,0.0001
Diabetic 99.9637.7 110.6638.0 100.7637.8
NG
{ (%) 43.5 64.7 48.2
T2D
{ (%) 51.9 16.0 43.6
CHD (%) 27.3 2.5 21.5
IGT/IFG
NN (%) 4.6 19.2 8.0
{Normoglycemic;
{Type II Diabetes;
NNImpaired glucose tolerance, Impaired fasting glucose,
YDifference between non-diabetic and diabetic.
*p,0.001;
**p=0.002;
¥p=0.02 (showing significant difference in the Punjabi and US cohorts).
doi:10.1371/journal.pone.0037056.t002
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(rs4420638) showed a moderate association with decreased
HDL-C Punjabi cohort and US cohort (online Table S2). Our
data could not confirm the association of CDK2A-2B (rs1333049)
with lipid traits or T2D (online Table S1, S2).
Association Analysis of Variants in the LD Region (the
chromosomal region 11q23.3) Spanning BUD13-ZNF259,
APOA5-A4-C3-A1, and SIK3 Genes with TG
After seeing strong and consistent association of two variants,
rs964184 (BUD13-ZNF259) and rs12286037 (ZNF259) with TG,
we analyzed a further 45 SNPs from the chromosomal region
11q23.3 spanning these two SNPs using genotyping data from our
ongoing North Indian (SDS) GWAS and genome-wide data
available from 6,530 participants in the London Life Sciences
Population (LOLIPOP) study. As shown in Figure 1 and Table 6,
six of 45 SNPs revealed a strong association with TG levels in both
SDS and LOLIPOP cohorts. Meta-analysis of these variants in the
combined sample of 8,530 individuals revealed significant p values
in both fixed- and random-effect models. The effect size of each
SNP for affecting TG in fixed-effect meta-analysis was (b=0.20,
p=7.52610
226; b=0.14, p=8.15.610
221; b=0.21,
p=1.06610
239; b=20.08, p=3.0610
24; b=0.08,
p=1.87610
28; b=20.09, p=9.28610
29), respectively for
rs7350481, rs180326, rs964184, rs618923, rs10047459, rs533556
(Table 6) showing the strongest p value (1.06610
239) for rs964184.
To further characterize the relationship between genotypes of
these variants and their impact on TG levels, we considered the
predictive value of the genotype score by counting the number of
risk alleles among these seven significant SNPs. As shown in
Figure 2, the genotype score of these seven SNPs showed a dose-
related increase in TG levels ranging from 140.066.9 mg/dL with
2–3 risk alleles to 229.2644.0 mg/dL with 9 risk alleles. There
was an overall increase of 89 mg/dL from 2 to 9 risk alleles (linear
regression p=1.62610
26). Individuals carrying more than 4 risk
alleles on average had fasting TG levels greater than the currently
acceptable level of TG (150 mg/dL) which would substantially
increase their risk for CAD and T2D, and raising implications for
early development of complications [16].
Two GWAS SNPs, rs964184 and rs12286037, were in tight LD
(D’=0.92) with each other in this sample (online Figure S3). We
performed step-wise regression to examine the independence of
the SNP effects including all significant SNPs along with age,
gender, and BMI. Only two SNPs, rs964184 and rs10047459,
remained significant in the final model. Interestingly, the strongest
signal (b=0.16, p=2.57610
25) remained associated with
rs964184 for TG (Table 7).
Haplotype Analysis
To further determine whether SNPs other than rs964184 and
rs12286037 account for any additional association with TG when
examined together, we performed haplotype analysis using the
seven most significant SNPs from the SDS GWAS including
rs964184 and rs12286037. As shown in Table 8, the analysis
revealed two haplotypes; ACGCAGA carrying ‘G’ risk allele (in
rs964184) to be associated with significantly raised TG (b=0.13,
4.62610
26, empirical p=9.0610
24), and GACCAAC carrying
‘C’ protective allele to be associated with significant reduced TG
concentrations (b=20.07, p=0.025, empirical p=0.034) in this
population. The least frequent haplotypes (,5%) were not
included in analysis. Note that the association of these haplotypes
with TG remained significant (ACGCAGA, p=2.34610
24 for
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after controlling for age, gender, and BMI.
To further understand and interpret these findings, we
performed conditional haplotype analysis by controlling for the
effect of two original SNPs (rs964184 and rs12286037). As shown
in the Table 8, the association of ACGCAGA haplotype with
increased TG (4.62610
26) and GACCAAC with reduced TG
(p=0.025) levels disappeared after including rs964184 in the
model. However, the same haplotypes remained linked with
increased TG (ACGCAGA, p=2.83610
26) and reduced TG
(GACCAAC, p=0.047) levels after controlling for rs12286037.
These results further confirm the putative role of rs964184 for
independently affecting TG concentrations.
Discussion
Our study has convincingly replicated the associations of two of
the six most associated GWAS SNPs with blood lipid phenotypes
in a non-European population. We previously reported a strong
association of rs3764261 from the promoter region of CETP gene
with HDL-C in our Punjabi cohort (n=2,431) [17]. Our current
data also provide strong evidence of association of rs3764261 with
HDL-C in our expanded cohort (Punjabi+US) separately (Punjabi:
n=2,902, b=0.09, 6.31610
25; US Asian Indians: n=879,
b=0.10, 1.72610
29), and combined in a meta-analysis
(n=3,781, b=0.14, 2.03610
226). The serum HDL-C levels
increased 13% in ‘AA’ carriers over those of common ‘CC’
carriers. These results are in agreement with this ‘A’ allele being
associated with raised HDL-C levels reported in previous GWAS
and meta-analysis studies in Caucasians [13,18]. The other
important confirmation in our findings was the robust association
of TG concentrations in this cohort with rs964184 from the inter-
genic region between BUD13 and ZNF259, and rs12286037 an
intronic variant from ZNF259 near APOA5-A4-C3-A1. The
APOA5-A4-C3-A1 locus is associated with plasma TG and
VLDL-C levels in several studies including Caucasian GWAS
and meta-analyses [8,18], Chinese [19], Asian Indians from UK
[20], US Whites and Blacks [21], and Middle-Easterns [22].
Notably, in our study, the allelic effects of these variants were
stronger under conditions of dyslipidemia associated with T2D
and the difference in effect size (b=0.16 T2D vs. b=0.10 NG
control) for rs964184 was statistically significant (p=0.01). These
results agree with earlier studies where the effect size of the loci
contributing to quantitative traits of CAD was magnified under
conditions of diabetes [23,24]. It also was interesting to observe
that not only the same risk alleles, ‘G’ of rs964184 (BUD13-
ZNF259) and ‘T’ of rs12286037 (ZNF259) were involved in raising
TG levels but also the effect sizes for per ‘G’ allele increase in TG
Table 4. Association of SNPs with lipid traits in US Cohort.
NG Controls Combined (NG Controls + T2D Cases)
b p-value b p-value b p-value b p-value b p-value b p-value
BUD13-ZNF259 rs964184 log additive dominant recessive log additive dominant recessive
TG (mg/dL) 0.12 0.005 0.13 0.002 0.03 0.484 0.18 2.46610
25 0.19 1.12610
25 0.08 0.058
ZNF259 rs12286037 log additive dominant recessive log additive dominant recessive
Cholesterol (mg/dL) 0.11 0.009 0.11 0.014 0.06 0.140 0.18 3.58610
25 0.17 1.09610
24 0.10 0.030
TG (mg/dL) 0.07 0.087 0.07 0.102 0.04 0.374 0.14 0.002 0.13 0.002 0.06 0.162
CETP rs3764261 log additive dominant recessive log additive Dominant recessive
Cholesterol (mg/dL) 0.09 0.040 0.09 0.051 0.06 0.177 0.03 0.018 0.04 0.025 0.04 0.109
HDL-C (mg/dL) 0.11 0.006 0.09 0.023 0.09 0.024 0.10 1.72610
29 0.11 1.96610
26 0.14 2.60610
26
Table 3b only contains most significant SNPs associated with lipid traits, details of the remaining SNPs can be found in online Table S1b.
doi:10.1371/journal.pone.0037056.t004
Table 5. Association of significant SNPs with lipid traits in the SDS cohort.
Punjabi Cohort US Cohort
Chr SNP Trait Risk Allele b (95%CI) p-value b (95%CI) p-value
11 rs964184 TG G 0.15 (0.09–0.18) 5.94610
210 0.18 (0.09–0.23) 2.46610
25
11 rs12286037 TG T 0.07 (0.05–0.23) 3.00610
23 0.14 (0.08–0.36) 2.00610
23
16 rs3764261 HDL-C A 0.09 (0.05–0.14) 1.21610
24 0.10 (0.07–0.13) 1.72610
29
Primary Meta-analysis (Punjabi and US Cohort)
SNP Trait Risk Allele b
(Fixed Effect)
p-value
(Fixed Effect)
b
(Random Effect)
p-value
(Random Effect)
p-value
(Heterogeneity)
rs964184 TG G 0.16 1.74610
217 0.16 1.74610
217 0.52
rs12286037 TG T 0.09 1.58610
22 0.09 1.58610
22 0.49
rs3764261 HDL-C A 0.14 2.03610
226 0.15 4.84610
24 0
doi:10.1371/journal.pone.0037056.t005
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US) and (19.3 mg/dL pooled) (Figure 3) when compared to
European populations (18.12 mg/dL) [18]. After further explora-
tion of this region 11q23.3 using 45 SNPs from this locus, other
SNPs in LD with the lead SNP (rs964184) were also associated
with TG showing high significance in the SDS and LOLIPOP
cohorts individually and in meta-analysis (Table 6). In the
presence of LD across the region, the precise causal variant
remains to be identified.
Upon analyzing these variants together in haplotype analysis,
two frequent haplotypes- ACGCAGA (frequency 10%) and
GACCAAC (frequency 18%) revealed a strongly significant
association with TG concentrations. The major effect appears to
be driven by rs964184 as the association of this haplotype
(ACGCAGA) with TG was no longer significant after analyzing
this haplotype combination conditional upon rs964184 (b=0.06,
p=0.204). However, the same haplotype (ACGCAGA) showed
strong association with raised TG levels (b=0.16, p=2.83610
26)
when analysis was controlled for rs12286037 (Table 8).
Our data show a weak association of rs599839, representing
CELSR2-PSRC1-SORT1, with reduced LDL-C levels in the
Punjabi cohort (b=20.06, p=0.011) and a non-significant trend
in the US cohort (b=20.03, p=0. 572) (online Tables S1 and
S2). This same variant was associated with LDL-C in Chinese
(p,0.001), Asian Indians (p=0.003), and Malays (p=0.004) from
Singapore [8] and showed a strong association with LDL-C in
a large-scale replication study in Japanese (p=3.1610
211) [25].
Our study could not replicate the association of the remaining
variants, especially the APOE-CI-C4-C2 cluster variant rs4420638
with LDL-C as reported in a Caucasian GWAS [26], and meta-
analysis [7]. Instead, our data showed a similar minor (at risk)
allele-associated decrease in HDL-C in both the Punjabi
(b=20.06, p=0.007) and US (b=20.09, p=0.032) cohorts.
Our data did not confirm associations of CDKN2A-2B (rs1333049)
with T2D, CAD, FBG, fasting insulin, or lipids as reported in
earlier studies [27]. We previously reported negative association of
another variant in CDKN2A-2B (rs10811661) with T2D and other-
related traits in this population [15] contrary to associations seen
in Caucasian populations [28,29]. The negative association of
these loci could be due to population stratification, phenotype
heterogeneity, evolutionary pressures, demographic and cultural
histories or a lack of power in our study to detect these small effects
Figure 1. Location of genetic markers in chromosomal region (11q23.3) (195 Kb) encompassing BUD13-ZNF259, APOA5-A4-C3-A1, and
SIK3 gene cluster. Exons are shown in black vertical rectangles separated by introns. Significant SNPs (associated with increased triglyceride
concentrations) detected in BUD13, ZNF259 and SIK3 are shown in large rectangles on disequilibrium (LD) matrix with their position on the genes
indicated by lines. The direction of transcription of genes is shown in arrows. Pair-wise LD between SNPs (D’) is indicated by diamonds shaded in
white-grey-black show the range of LD matrix from D’=0 in white to D’=1 in black. LD block 1 contains 5 most significant SNPs including two top
SNPs (rs964184 and rs7350481) of the total 45 analyzed. LD block 2 shows all SNPs from the SIK3 gene and the presence of a strong LD among these
SNPs containing two strong signals associated with triglycerides in rs10047459 and rs533556.
doi:10.1371/journal.pone.0037056.g001
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environment interactions, or phenotypic variability due to
differences in biological adaptation or other factors are the cause
for the poor replication [11]. Many times the high risk variant may
be restricted to certain populations, for instance, the restricted
association of KCNQ1 SNPs (rs2237892, rs2237897) with T2D in
East Asians because of the significant variation of allele frequency
across ethnic groups [30]. On the other hand, if the same variant is
showing association with disease or traits in diverse populations,
validation studies enable more generalizable estimates of effect
sizes in the general population [31].
It is interesting to observe that the variants identified by GWAS,
especially those related to lipid regulation also are associated with
CAD. A CAD risk locus associated with rs599839 in the CELSR2-
PSRC1-SORT1 region was not only associated with elevated LDL-
C concentrations, but also with CAD [32]. These findings suggest
that the locus association with CAD may be mediated though its
effect on LDL-C levels, although we could not confirm the role of
this variant (rs599839) with CAD in this sample. On the other
hand, many times the relationship of a SNP with a trait may be
direct but not with the main disease due to the multifactorial
nature of the disease. For instance, within the 11q23.3 region,
although our findings revealed a direct causal relationship between
the SNP and the trait (TG), none of the variants from this locus
was associated with T2D or CAD as has been observed for the
LDL-CAD locus on chromosome 1. The ‘less common’ variants
possibly reveal a ‘common’ association with TG and disease
(T2D/CAD). A recent targeted resequencing study conducted on
patients with severe hypertriglyceridemia (HTG) for APOA5
detected an abundance of rare variants in HTG patients with
T2D in comparison to those without T2D (25% vs. 6.1%,
p=0.037) [33]. These findings suggest the co-inheritance of TG
raising alleles with other physiological factors operating together in
the common pathway leading to T2D. Even in this investigation,
the allelic contribution of the SNP rs964184 was increased from
b=0.10 in non-diabetics to b=0.16 in diabetics (p=0.01)
(Table 3).
Most of these GWAS variants belong to inter-genic or non-
coding regions. These may have influence on the transcriptional
binding sites of the adjacent genes or may interfere with the
transcriptional mechanisms without being directly involved in
protein regulation. The ZNF259 gene is located ,1.6 Kb
upstream of the APOA5-A4-C3-A1 gene cluster, and the top
ranking SNP influencing TG levels (rs964184) resides in the
intergenic region between BUD-13 and ZNF259. ZNF259 is
a regulatory protein involved in cell proliferation and signal
transduction and may have multiple physiological functions [34].
The most relevant transcription factors that bind to the promoter
site of ZNF259 include proxisome proliferator activated receptor
gamma (PPARG1 and PPARG2), and hepatocyte nuclear receptor
alpha (HNF4a1 and HNF4a2). Nuclear receptors PPARG 1 and 2
are expressed in diverse tissues and have been used as targets for
improving insulin sensitivity and are widely studied for their role in
insulin sensitivity and obesity together with influencing the
transcription of several target genes [35,36]. HNF4a 1 and 2
nuclear receptors are linked to several human diseases and are
known to activate a variety of genes involved in glucose, fatty acid,
and cholesterol metabolism in the liver, kidney, intestine, and
pancreas [37]. Therefore, an in-depth study of the remotely
controlled regulatory mechanisms is needed to clarify which SNPs
are functional and how these genes actually influence circulating
TG concentrations.
Although none of the six SNPs most associated with TG actually
belong to the APOA5-A4-C3-A1 gene cluster the presence of two
top signals (rs964184, p=1.06610
239 and rs7350481,
p=7.52610
226) within this LD region (stretching up to
,65.9 Kb interval in block 1) (Figure 1 and Table 6) suggests
the possible presence of rare or less frequent causal variants in this
region. Confirmation of positive associations in some of the
strongest GWAS signals, CETP (rs3726461) with HDL-C and
Table 6. Association of six most significant SNPs within BUD13-ZNF259, A5-A4-C3-A1, and SIK3 with TG.
Punjabi (SDS) Cohort n=2,000 LOLIPOP Cohort n=6,530
SNP Risk allele CEU Allele Frq. b SE p-value Allele Frq. b SE p-value
rs7350481 A 0.08 0.2 0.12 0.03 9.18610
26 0.21 0.27 0.03 3.91610
225
rs180326 C 0.33 0.35 0.06 0.02 0.009 0.35 0.23 0.02 5.01610
226
rs964184 G 0.12 0.21 0.11 0.02 3.42610
26 0.22 0.36 0.02 3.06610
245
rs618923 A 0.76 0.82 20.08 0.03 0.002 0.84 20.07 0.03 0.013
rs10047459 G 0.16 0.38 0.06 0.02 0.007 0.39 0.11 0.02 4.63610
27
rs533556 A 0.3 0.34 20.06 0.02 0.005 0.36 20.12 0.02 1.57610
27
Joint Meta-analysis n=8,530
SNP Risk
allele
b
(Fixed
Effect)
p-value
(Fixed
Effect)
b
(Random
Effect)
p-value
(Random Effect)
p-value
(Heterogeneity)
rs7350481 A 0.2 7.52610
226 0.19 8.00610
23 2.00610
24
rs180326 C 0.14 8.15610
221 0.15 0.09 0
rs964184 G 0.21 1.06610
239 0.23 5.80610
22 0
rs618923 A 20.08 3.0610
24 20.08 2.00610
24 0.851
rs10047459 G 0.08 1.87610
28 0.08 7.00610
24 0.094
rs533556 A 20.09 9.28610
29 20.09 0.001 0.059
Genotyping on rs12286037 was not available in LOLIPOP sample.
doi:10.1371/journal.pone.0037056.t006
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ascertained non-European populations of Indian origin validate
the strength of GWAS studies and their usefulness and potential to
find disease loci affecting complex chronic disorders. However, the
identified genes and inter-genic variants most likely represent just
the tip of the iceberg for cardiovascular risk as the overall residual
variance contributed by these SNPs is ,5% and even the meta-
analysis ORs do not exceed 1.22. These findings suggest that rarer
or less common variants which are currently invisible in GWAS
may exist within these regions. Further fine mapping and targeted
resequencing in these gene regions in different ethnicities, as well
as functional studies, would help detection of putative loci of
therapeutic significance.
Methods
Human Subjects- Punjabi and US Cohorts
DNA and serum samples from a total of 3,781 individuals
(2,902 Punjabi Cohort [52% T2D]; 879 US Cohort [16%T2D])
were studied. The healthy control participants from the Punjabi
cohort were random unrelated individuals recruited from the same
Asian Indian community as the T2D patients and matched for
ethnicity and geographic location. The US subjects were recruited
through public advertisement as part of a population-based study
involving free health screening for cardiovascular risk factors. The
individuals with mixed ancestry or non-Asian Indian ancestry were
not enrolled. Two third of the participants from the US cohort
were originally from the state of Punjab, and the remaining one
third were from other western and southern states of India. Men
and women aged 25–79 years participated. The diagnoses of T2D
were confirmed by reviewing medical records for symptoms, use of
medication, and measuring FBG levels following the guidelines of
the American Diabetes Association (2004) [38], as described in
detail previously [39]. A medical record indicating either (1) a FBG
$126 mg/dL or $7.0 mmol/L after a minimum 12 h fast or (2)
a 2 h post-glucose level (2 h oral glucose tolerance test) $200 mg/
dL or $11.1 mmol/L on more than one occasion, combined with
symptoms of diabetes, confirmed the diagnosis. Impaired fasting
glucose (IFG) was defined as a fasting blood glucose level
$100 mg/dL (5.6 mmol/L) but #126 mg/dL (7.0 mmol/L).
Impaired glucose tolerance (IGT) was defined as a 2 h OGTT
.140 mg/dL (7.8 mmol/L) but ,200 mg/dL (11.1 mmol/L).
Participants with IFG or IGT were considered pre-diabetics and
were analyzed separately. The 2h OGTTs were performed
following the criteria of the World Health Organizations (WHO)
(75 g oral load of glucose). BMI was calculated as (weight [kg]/
Figure 2. Figure 2 shows the distribution of serum triglyceride levels in Punjabi, US and entire cohort stratified by rs964184
genotypes. Multiple linear regression analysis was performed using age, BMI and gender in individuals cohorts and age, BMI, gender and place of
birth as combined cohorts. P-values in the bars show statistically significant association of ‘G’ risk allele with triglycerides.
doi:10.1371/journal.pone.0037056.g002
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2). Participants with type I diabetes, or those having
a family member with type I diabetes, or rare forms of T2D sub-
types (maturity onset diabetes of young [MODYs]), or secondary
diabetes (from e.g. hemochromatosis, pancreatitis) were excluded
from the study.
Controls, clinically free of T2D, IGT, or IFG, were selected
based on a fasting glycemia ,100.8 mg/dL (,5.6 mmol/L) or
a 2 h glucose ,141.0 mg/dL (,7.8 mmol/L). Participants with
IFG or IGT were excluded when data were analyzed for
association of variants with T2D. All blood samples were obtained
at the baseline visits. All participants signed a written informed
consent for the investigations. The study was reviewed and
approved by the University of Oklahoma Health Sciences Center’s
Institutional Review Board, as well as the Human Subject
Protection Committees at the participating hospitals and institutes
in India.
Metabolic Assays
Insulin was measured by radio-immuno assay (Diagnostic
Products, Cypress, USA). HOMA IR (fasting glucose x fasting
insulin)/22.5 and HOMA B (fasting insulin x 20/FBG 23.5), were
calculated as described [40]. Serum lipids [total cholesterol, LDL-
C, HDL-C, VLDL-C, and TG] were measured using standard
enzymatic methods (Roche, Basel, Switzerland) as described
previously [41].
SNP Genotyping
We genotyped six SNPs from GWAS derived loci (CELSR2-
PSRC1-SORT1 rs599839; CDKN2A-2B rs1333049; BUD13-
ZNF259 rs964184; ZNF259 rs12286037; CETP rs3764261;
APOE-C1-C4-C2 rs4420638). Details of the investigated loci, their
previously reported association with lipid phenotypes (traits), allele
frequency, effect size, population studied etc. are summarized in
Table 2. Genotyping for these six SNPs was performed using
TaqMan pre-designed or TaqMan made-to-order SNP genotyp-
ing assays from Applied Biosystems Inc. (ABI, Foster City, USA).
Genotyping reactions were performed on an ABI 7900HT genetic
analyzer using 2 uL of genomic DNA (10 ng/uL), following
manufacturers’ instructions. For quality control, 8–10% replicate
controls and 4–8 negative controls were used in each 384 well
plate to match the concordance, and the discrepancy rate in
duplicate genotyping was ,0.2%. Genotyping call rate was 97%
or more in all the SNPs studied.
LOLIPOP Cohort (UK)
Assessment of LOLIPOP participants was carried out by trained
research nurses, according to a standardized protocol and with
regular quality control (QC) audits as described previously [42].
T2D cases were selected based on physician diagnosis of diabetes
on treatment, with onset of diabetes after the age of 18 years and
without insulin use in the first year after diagnosis, or FBG
.126 mg/dL on 2 or more occasions [38]. Controls were selected
based on no history of diabetes, and FBG ,110 mg/dL. An
interviewer-administered questionnaire was used to collect data on
medical history, family history, current prescribed medication
(verified from the practice computerized records), cardiovascular
risk factors, alcohol intake, physical activity, and socio-economic
status. Country of birth of participants, parents, and grandparents
was recorded together with language and religion for assignment
of ethnic subgroups. Physical assessments including blood pres-
sure, anthropometric measurements (height, weight, and WHR),
fat mass (bio-impedance), urinalysis, and 12 lead ECG. FBG,
insulin, total, HDL-C and LDL-C, TG, were measured on all
participants as described previously [6]. At the time of this analysis
genotype and phenotype data on 6,530 individuals comprising
1,774 T2D cases and 4,756 controls were available from this
study.
GWAS
Genome-wide association scans in LOLIPOP and SDS samples
were performed using Illumina Infinium Beadchips genotypes
Table 7. Test of independence: step-wise multiple linear
regression showing association of SNPs with TG using full
model
{.
Included in the model
Model Effect P-value
1 BMI 0.02 (0.01–0.03) 1.33610
24
2 BMI 0.02 (0.01–0.03) 5.25610
25
rs964184 0.12 (0.05–0.19) 4.73610
24
3 BMI 0.02 (0.01–0.03) 1.15610
24
rs10047459 0.15 (0.04–0.26) 0.01
rs964184 0.16 (0.08–0.23) 2.57610
25
Excluded from the model
Model Effect p-value
1 Sex 20.02 0.65
Age 0.00 0.98
Disease 0.05 0.26
rs7350481 0.14 3.05610
23
rs180326 0.12 0.01
rs964184 0.16 4.73610
24
rs12286037 0.10 0.04
rs10047459 0.07 0.16
rs533556 20.11 0.02
rs618923 20.07 0.16
2 Sex 20.03 0.54
Age 0.00 0.96
Disease 0.05 0.27
rs7350481 0.10 0.04
rs180326 0.09 0.05
rs12286037 0.05 0.34
rs618923 20.13 0.01
rs10047459 0.13 0.01
rs533556 20.08 0.11
3 Sex 20.04 0.43
Age 20.01 0.88
Disease 0.06 0.22
rs7350481 0.08 0.10
rs180326 0.07 0.16
rs12286037 0.02 0.64
rs618923 – –
rs533556 20.04 0.48
{Includes age, BMI, gender, disease, and rs7350481, rs180326, rs12286037,
rs964184, rs618923, rs10047459, rs533556 in the model.
doi:10.1371/journal.pone.0037056.t007
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Controlling for the
effect of rs964184 Controlling for the effect of rs12286037
Haplotype Frq b (95% CI)
Unadjusted
p Adjusted p* Trait effect b (95% CI)
Adjusted
p b (95% CI) Adjusted p Trait effect
ACGCAGA* 0.10 0.13 (0.06 – 0.20) 4.62610
26 2.34610
24 q 0.06 (20.03 –
0.15)
0.204 0.16 (0.09 - 0.23) 2.83610
26 q
GACCAGC 0.06 0.01 (20.08 –
0.11)
0.826 0.769 0.05 (20.05 –
0.14)
0.333 0.00 (20.10 – 0.09) 0.949
GACCAAA 0.18 20.02 (0.04 –
20.08)
0.137 0.531 0.01 (20.05 –
0.07)
0.786 20.04 (20.09 – 0.02) 0.221
GACCAGA 0.13 20.02 (0.04 –
20.08)
0.350 0.511 20.01 (20.07 –
0.05)
0.813 20.02 (20.08 – 0.04) 0.434
GACCAAC
{ 0.18 20.07 (20.01 –
20.12)
0.025 0.015 Q 20.03 (20.08 –
0.03)
0.296 20.05 (20.11 – 0.00) 0.047 Q
GCCCGAC 0.09 20.08 (20.01 –
20.16)
0.110 0.034 20.02 (20.09 –
0.05)
0.562 20.05 (20.13 – 0.02) 0.138
rs7350481; rs180326; rs964184; rs12286037; rs618923; rs10047459; rs533556; *Empirical p=9.0610
24;
{Empirical p=0.034; *adjusted for age, gender, and BMI.
doi:10.1371/journal.pone.0037056.t008
Figure 3. Figure 3 shows the combined effect of risk alleles of for elevating triglyceride levels from BUD13 (rs7350481 rs180326),
inter-genic variant from BUD13-ZNF259 (rs964184), and intronic variants from ZNF259 (12286037 and rs618923), and SIK3
(rs100447459, rs533556). Y axis represents mean triglyceride levels and X axis represents number of risk alleles with the number of participants
per risk allele shown in parenthesis below. Rectangles in the plot indicate mean values of triglycerides separated by each risk-allele group and error
bars are 95% CI. Note that the the cumulative gene-score of all significant SNPs showed a dose-related increase in TG concentrations ranging from
(140.066.9 mg/dL with 2–3 risk alleles to 229.2644.0 mg/dL with 9 risk allele carriers with overall effect increased to 89 mg/dL from 2 to 9 risk alleles
(p=1.62610
26 ).
doi:10.1371/journal.pone.0037056.g003
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a SNP call rate ,95% were removed, as were SNPs with call rate
,97%, minor allele frequency ,1%, or HWE p,1.0610
26.
Principal components analysis (PCA) was used in both GWAS
datasets to control for population stratification by comparison to
reference samples from the Hapmap YRI, CHB, JPT and CEU
panels using PLINK (http://pngu.mgh.harvard.edu/ ˜purcell/
plink/) and Eigensoft [43], and the Indian samples collected by
Reich and colleagues [44]. Samples with eigenvalues inconsistent
with Asian Indian ancestry were removed as described previously
[45].
Statistical Analysis
Data quality for SNP genotyping was checked by establishing
reproducibility of control DNA samples. Departure from HWE in
controls was tested using the Pearson chi-square test. The
genotype and allele frequencies in T2D cases were compared to
those in control subjects using the chi-square test. Statistical
evaluation of genetic effects on T2D risk used multivariate logistic
regression analysis with adjustments for age, gender, and other
covariates. Continuous traits with skewed sampling distributions
(e.g., TG and total cholesterol) were log-transformed before
statistical analysis. However, for illustrative purposes, values were
re-transformed into the original measurement scale. Supplemen-
tary Figure S2 shows the distribution of serum TG levels before
and after transformation. General linear models were used to test
the impact of genetic variants on transformed continuous traits.
Country of birth was used as a covariate when analyzing the
combined sample of the Punjabi and US cohorts. Other significant
covariates for each dependent trait were identified by Spearman’s
correlation and step-wise multiple linear regression with an overall
5% level of significance using SPSS for Windows statistical
package (version 18.0) (SPSS Inc., Chicago, USA). Mean values
between cases and controls were compared by using an unpaired t-
test. To adjust for multiple testing, we used Bonferroni’s correction
(0.05/number of tests performed).
Haplotype analysis of BUD13-ZNF259 rs964184, ZNF259
rs12286037, and other significant SNPs analyzed from the
195 Kb region surrounding these two variants was performed
using HAPLOVIEW (version 4.0) which uses an accelerated
expectation maximization algorithm to calculate haplotype
frequencies (http://www.broadinstitute.org/haploview/
haploview). Effect of seven-site haplotype on quantitative traits
were determined using PLINK. Meta-analysis was performed by
using PLINK for fixed-effects and random-effects models and the
p value for heterogeneity was derived from Cochrane’s Q statistics.
The fixed effect meta-analysis is based on the assumption that
a single common (or fixed) effect underlies each study in the meta-
analysis. Random effect meta-analysis provides information about
the distribution of effects across different studies. Design of the
meta-analysis is described in a flow chart (online Figure S1).
Statistical power was assessed using the Genetic Power
Calculator [46]. The general estimates of power in the Punjabi
and combined sample using an additive genetic model at a=0.05,
K=0.18 for detecting the effect sizes between 1.12 and 1.58 for
T2D, were 56% and 89% in the Punjabi and 66% and 97% in
combined cohorts, respectively, when the frequency of risk alleles
were 0.82 and 0.35, respectively, in our sample. However, for
quantitative traits, the power was well in excess (90%) to detect the
inter-genotype difference (e.g. for TG levels), assuming an additive
genetic model, (a=0.05, and Bonferroni’s p=0.008) at allele
frequencies ranging from 0.05–0.89 using, 1,262, 569, and 1,861
controls from the Punjabi, US, and combined cohorts, re-
spectively. This power is associated to detect a difference in
a quantitative trait of TG of as little as 1 mg/dL and accounts for
an effect size of 0.1 which corresponds to detecting significant b’s
outside of the range of 60.05.
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